Gaetana Rinaldi

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Ester Simeone, Giusy Gentilcore, Diana Giannarelli et al. · Cancer Immunology Immunotherapy · 2014 · 250 citations · Full text

Medicine, Immunology, Oncology +17

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

Laura D. Locati, Paolo Bossi, Federica Perrone et al. · Oral Oncology · 2008 · 217 citations

Medicine, Oncology, Metastasis +11

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni et al. · Journal of Translational Medicine · 2014 · 163 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)

Laura D. Locati, Federica Perrone, Marco Losa et al. · Oral Oncology · 2009 · 159 citations

Medicine, Cancer Biology, Oncology +14

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

Michele Del Vecchio, Lorenza Di Guardo, Paolo A. Ascierto et al. · European Journal of Cancer · 2013 · 157 citations · Full text

Medicine, Oncology, Pharmacology +12